Matthew Lumley
Directeur Général chez Myosana Therapeutics, Inc.
Postes actifs de Matthew Lumley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 01/01/2023 | - |
Myosana Therapeutics, Inc.
 Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Directeur Général | 01/11/2021 | - |
| Directeur/Membre du Conseil | 01/11/2021 | - |
Historique de carrière de Matthew Lumley
Formation de Matthew Lumley
| King's College London | Doctorate Degree |
| Imperial College London | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Matthew Lumley
- Expérience
